Frontiers in endocrinology · 2026
The predictive value of fresh embryo transfer pregnancy results on frozen embryo transfer outcomes: a cohort study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ren Anqi, Xue Xia, Shi Juanzi, He Tingting, Shi Wenhao
Аннотация
OBJECTIVE: To investigate whether the outcome of a fresh embryo transfer can predict the results of subsequent frozen embryo transfers (FET) in patients undergoing single blastocyst transfer.
DESIGN: Retrospective cohort study.
SETTING: Tertiary-care academic medical center.
PATIENTS: This retrospective study involved a total of 6,491 women who underwent single blastocyst transfer in FET cycles from January 2016 to June 2024. Women were categorized into four groups based on their fresh transfer outcomes: the non-pregnancy group (n=3,711), biochemical pregnancy group (n=701), miscarriage group (n=1,066), and live birth group (n=1,013).
INTERVENTIONS: None.
MAIN OUTCOME MEASURES: Live birth rates.
RESULTS: Compared with the fresh-cycle live birth group, patients in fresh-cycle non-pregnancy, biochemical pregnancy, and miscarriage groups exhibited significantly lower chance of subsequent biochemical pregnancy (adjusted odds ratio [aOR]=0.58, 95% confidence interval [CI]: 0.50-0.68; aOR=0.70, 95% CI: 0.56-0.87; aOR=0.72, 95% CI: 0.60-0.88, respectively), clinical pregnancy (aOR=0.57, 95% CI: 0.49-0.66; aOR=0.65, 95% CI: 0.53-0.80; aOR=0.71, 95% CI: 0.59-0.85, respectively), and live birth (aOR=0.59, 95% CI: 0.51-0.68; aOR=0.71, 95% CI: 0.58-0.86; aOR=0.65, 95% CI: 0.54-0.77, respectively). However, no significant differences were observed in the rates of miscarriage or ectopic pregnancy among the four groups (P>0.05 for all). Further subgroup comparison demonstrated that compared with fresh-cycle non-pregnancy group, patients with prior fresh-cycle miscarriage had significantly higher rate biochemical pregnancy (aOR=1.12, 95% CI: 1.04-1.20), clinical pregnancy (aOR=1.12, 95% CI: 1.05-1.21), and miscarriage (aOR=1.14, 95% CI: 1.03-1.26), whereas the rates of ectopic pregnancy and live birth were remained comparable between the two groups (P>0.05 for all).
CONCLUSIONS: In conclusion, compared with patients who achieved live birth in the fresh cycle, those in the non-pregnancy, biochemical pregnancy, and miscarriage groups had significantly lower chances of achieving biochemical pregnancy, clinical pregnancy, and live birth in subsequent FET cycles. These findings suggest that the outcome of fresh embryo transfer can serve as a potential predictive indicator for subsequent FET pregnancy prognosis, providing valuable clinical guidance for individualized counseling and management of patients undergoing assisted reproductive technology (ART) treatment.
DESIGN: Retrospective cohort study.
SETTING: Tertiary-care academic medical center.
PATIENTS: This retrospective study involved a total of 6,491 women who underwent single blastocyst transfer in FET cycles from January 2016 to June 2024. Women were categorized into four groups based on their fresh transfer outcomes: the non-pregnancy group (n=3,711), biochemical pregnancy group (n=701), miscarriage group (n=1,066), and live birth group (n=1,013).
INTERVENTIONS: None.
MAIN OUTCOME MEASURES: Live birth rates.
RESULTS: Compared with the fresh-cycle live birth group, patients in fresh-cycle non-pregnancy, biochemical pregnancy, and miscarriage groups exhibited significantly lower chance of subsequent biochemical pregnancy (adjusted odds ratio [aOR]=0.58, 95% confidence interval [CI]: 0.50-0.68; aOR=0.70, 95% CI: 0.56-0.87; aOR=0.72, 95% CI: 0.60-0.88, respectively), clinical pregnancy (aOR=0.57, 95% CI: 0.49-0.66; aOR=0.65, 95% CI: 0.53-0.80; aOR=0.71, 95% CI: 0.59-0.85, respectively), and live birth (aOR=0.59, 95% CI: 0.51-0.68; aOR=0.71, 95% CI: 0.58-0.86; aOR=0.65, 95% CI: 0.54-0.77, respectively). However, no significant differences were observed in the rates of miscarriage or ectopic pregnancy among the four groups (P>0.05 for all). Further subgroup comparison demonstrated that compared with fresh-cycle non-pregnancy group, patients with prior fresh-cycle miscarriage had significantly higher rate biochemical pregnancy (aOR=1.12, 95% CI: 1.04-1.20), clinical pregnancy (aOR=1.12, 95% CI: 1.05-1.21), and miscarriage (aOR=1.14, 95% CI: 1.03-1.26), whereas the rates of ectopic pregnancy and live birth were remained comparable between the two groups (P>0.05 for all).
CONCLUSIONS: In conclusion, compared with patients who achieved live birth in the fresh cycle, those in the non-pregnancy, biochemical pregnancy, and miscarriage groups had significantly lower chances of achieving biochemical pregnancy, clinical pregnancy, and live birth in subsequent FET cycles. These findings suggest that the outcome of fresh embryo transfer can serve as a potential predictive indicator for subsequent FET pregnancy prognosis, providing valuable clinical guidance for individualized counseling and management of patients undergoing assisted reproductive technology (ART) treatment.